These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34155647)

  • 21. Noninvasive Fetal RhD Blood Group Genotyping: A Systematic Review of Economic Evaluations.
    Gajic-Veljanoski O; Li C; Schaink AK; Guo J; Higgins C; Shehata N; Okun N; de Vrijer B; Pechlivanoglou P; Ng V; Sikich N
    J Obstet Gynaecol Can; 2021 Dec; 43(12):1416-1425.e5. PubMed ID: 34390866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal screening service for fetal RHD genotyping to guide prophylaxis: the two-year experience of the Friuli Venezia Giulia region in Italy.
    Londero D; Merluzzi S; Dreossi C; Barillari G
    Blood Transfus; 2023 Mar; 21(2):93-99. PubMed ID: 35848630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Invasive Prenatal Fetal Blood Group Genotype and Its Application in the Management of Hemolytic Disease of Fetus and Newborn: Systematic Review and Meta-Analysis.
    Alshehri AA; Jackson DE
    Transfus Med Rev; 2021 Apr; 35(2):85-94. PubMed ID: 33781630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD-negative women: a systematic review and meta-analysis.
    Yang H; Llewellyn A; Walker R; Harden M; Saramago P; Griffin S; Simmonds M
    BMC Med; 2019 Feb; 17(1):37. PubMed ID: 30760268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive fetal RhD genotyping from maternal blood.
    Kolialexi A; Tounta G; Mavrou A
    Expert Rev Mol Diagn; 2010 Apr; 10(3):285-96. PubMed ID: 20370586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of RHD fetal genotype in RhD negative women.
    Kratochvílová T; Böhmová J; Durdová V; Vodička R; Holusková I; Langová K; Lubušký M
    Ceska Gynekol; 2020; 85(3):156-163. PubMed ID: 33562966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of non-invasive fetal RhD genotyping on management costs of rhesus-D negative patients: results of a French pilot study.
    Benachi A; Delahaye S; Leticee N; Jouannic JM; Ville Y; Costa JM
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):28-32. PubMed ID: 22386678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of RHD zygosity using real-time quantitative PCR.
    Li Y; Zimmermann B; Zhong XY; Gupta AK; Holzgreve W; Hahn S
    Swiss Med Wkly; 2003 Aug; 133(31-32):442-5. PubMed ID: 14562188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.
    Szczepura A; Osipenko L; Freeman K
    BMC Pregnancy Childbirth; 2011 Jan; 11():5. PubMed ID: 21244652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of diagnostic strategy for non-invasive cell-free foetal RHD determination from maternal plasma.
    Pazourkova E; Zednikova I; Korabecna M; Kralova J; Pisacka M; Novotna M; Calda P; Horinek A
    Vox Sang; 2021 Oct; 116(9):1012-1019. PubMed ID: 33761162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Confirmed non-invasive prenatal testing for foetal Rh blood group genotyping along with bi-allelic short insertion/deletion polymorphisms as a positive internal control.
    Armstrong-Fisher S; Koushki K; Mashayekhi K; Urbaniak SJ; van der Schoot E; Varzi AM
    Transfus Med; 2022 Apr; 32(2):141-152. PubMed ID: 35261100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies.
    Freeman K; Szczepura A; Osipenko L
    Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):91-8. PubMed ID: 19081172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Non-invasive fetal RHD genotyping: Validation of the method with 200 patients].
    Guinchard E; Bricca P; Monnier S; Rigal D
    Transfus Clin Biol; 2014 Mar; 21(1):1-14. PubMed ID: 24559796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Terminating Routine Cord Blood RhD Typing of the Newborns to Guide Postnatal Anti-D Immunoglobulin Prophylaxis Based on the Results of Fetal RHD Genotyping.
    Stensrud M; Bævre MS; Alm IM; Wong HY; Herud I; Jacobsen B; de Vos DDJA; Stjern HE; Sørvoll IH; Barane JB; Bagås TE; Rasmussen M; Ulvahaug N; Wamstad V; Tomter G; Akkök CA
    Fetal Diagn Ther; 2023; 50(4):276-281. PubMed ID: 37379821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluation.
    Saramago P; Yang H; Llewellyn A; Walker R; Harden M; Palmer S; Griffin S; Simmonds M
    Health Technol Assess; 2018 Mar; 22(13):1-172. PubMed ID: 29580376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive fetal RhD genotyping.
    Clausen FB; Damkjær MB; Dziegiel MH
    Transfus Apher Sci; 2014 Apr; 50(2):154-62. PubMed ID: 24642067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-throughput, non-invasive prenatal testing for fetal Rhesus D genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis.
    Saramago P; Yang H; Llewellyn A; Palmer S; Simmonds M; Griffin S
    BJOG; 2018 Oct; 125(11):1414-1422. PubMed ID: 29415334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women.
    Rouillac-Le Sciellour C; Puillandre P; Gillot R; Baulard C; Métral S; Le Van Kim C; Cartron JP; Colin Y; Brossard Y
    Mol Diagn; 2004; 8(1):23-31. PubMed ID: 15230639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.